한글목차

세계의 OTC 의약품 및 식이보충제 시장은 2018년에 2,233억 1,290만 달러로 평가되며, 2023년까지 CAGR 6.0% 이상으로 성장했습니다.

의약품 연구개발(R&D) 지출의 증가

제약회사의 연구개발(R&D) 지출 증가는 지금까지 OTC 의약품 및 식이보충제 시장의 성장을 주도했습니다. 연구개발(R&D)에 대한 투자 증가는 첨단 OTC 의약품 및 식이보충제의 창출로 이어졌습니다. 이러한 기술 혁신은 우수한 제형, 개선된 전달 방법, 개선된 안전 표준을 포함하며 소비자들 사이에서 제품의 매력을 높이고 있습니다. 예를 들어 벨기에에 본사를 둔 제약업계 단체인 유럽제약산업협회(European Federation of Pharmaceuticals Industries and Associations)가 발표한 보고서에 따르면 2021년 유럽 제약업계는 R&D에 약 415억 유로(444억 7,000만 달러)를 투자하여 2020년 396억 5,000만 유로(424억 9,000만 달러)에 비해 증가한다고 합니다. 따라서 제약회사의 연구개발(R&D) 지출 증가가 OTC 의약품 및 식이보충제 시장의 성장을 지원하고 있습니다.

목차

제1장 개요

• OTC 의약품 및 식이보충제 - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 도표 리스트

제5장 리포트 구성

제6장 시장의 특징

• 일반 시장 정의
• 개요
• OTC 의약품 및 식이보충제 - 시장 정의와 세분화
• 시장 세분화 : 카테고리별
  • 비타민과 식이보충제
  • 기침약·감기약
  • 진통제
  • 위장약
  • 피부
  • 기타 카테고리
• 시장 세분화 : 제형별
  • 정제
  • 하드 캡슐
  • 분말
  • 연고
  • 소프트 캡슐
  • 액체
  • 기타 제형
• 시장 세분화 : 유통 채널별
  • 약국
  • 식료품점
  • 비타민과 건강식품점
  • 온라인 약국

제7장 주요 시장 동향

• 식이보충제 및 OTC 의약품의 생산능력 확대
• 오피오이드 과잉 섭취를 역전시키는 새로운 시판약 옵션
• 수유중인 산모를 위한 천연 허브 기반 보충제의 발매
• 통증 및 알레르기를 완화시키는 시판약 라인의 서론
• 여성 건강 의약품의 혁신

제8장 OTC 의약품 및 식이보충제 시장 - 거시경제 시나리오

• COVID-19의 영향 : OTC 의약품 및 식이보충제 시장
• 우크라이나 전쟁의 영향 : OTC 의약품 및 식이보충제 시장
• 고인플레이션의 영향 : OTC 의약품 및 식이보충제 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 성장 촉진요인, 2018-2023
  • 시장 성장 억제요인, 2018-2023
• 시장 성장 예측, 2023-2028, 2033F
  • 시장 성장 촉진요인, 2023-2028
  • 시장 성장 억제요인, 2023-2028

제10장 세계의 OTC 의약품 및 식이보충제 시장 : 세분화

• 세계의 OTC 의약품 및 식이보충제 시장 : 카테고리별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 OTC 의약품 및 식이보충제 시장 : 제형별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 OTC 의약품 및 식이보충제 시장 : 유통 채널별, 실적과 예측, 2018-2023, 2028F, 2033F

제11장 OTC 의약품 및 식이보충제 시장 : 지역·국가별 분석

• 세계의 OTC 의약품 및 식이보충제 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 OTC 의약품 및 식이보충제 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• Nestle S.A.
• The Procter & Gamble Company
• Haleon plc
• Abbott Laboratories
• Sanofi S.A

제20장 기타 대기업과 혁신적 기업

• Reckitt Benckiser Group plc
• Bayer AG
• Church & Dwight Co. Inc
• Nature's Bounty Co
• Perrigo Company plc
• GNC Holdings Inc.
• Sun Pharmaceutical Industries Ltd
• Novartis AG
• Pfizer Inc
• Merck & Co. Inc
• Pharmavite LLC
• Hain Celestial Group Inc
• Blackmores Limited
• Cipla Inc
• Amway

제21장 경쟁 벤치마킹

제22장 경쟁 대시보드

제23장 주요 합병과 인수

• Dr. Reddy's Laboratories Acquired MenoLabs
• Dexcel Pharma Acquired Teva Pharmaceutical Industries Ltd
• Cipla Limited Acquired Actor Pharma
• SGS S.A. Acquired Nutrasource Pharmaceutical and Nutraceutical Services Inc.
• The Kirin Holdings Company Limited Acquired Blackmores Limited
• Balchem Corporation Acquired Bergstrom Nutrition
• Glenmark Pharmaceuticals Ltd Acquired Wockhardt Ltd
• Acino Acquired Aspen Pharmacare Holdings Limited
• Douglas Acquired Disapo
• Merieux NutriSciences Acquired Dyad Labs
• Laboratorios Rubio Acquired Fisiopharma S.r.l.
• Fidia Farmaceutici Acquired Sanofi

제24장 기회와 전략

• 세계의 OTC 의약품 및 식이보충제 시장, 2028 : 새로운 기회를 제공하는 국가
• 세계의 OTC 의약품 및 식이보충제 시장, 2028 : 새로운 기회를 제공하는 부문
• 세계의 OTC 의약품 및 식이보충제 시장, 2028 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제25장 OTC 의약품 및 식이보충제 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

영문목차

The OTC (over the counter) drug and dietary supplement market encompasses products that consumers can purchase without a prescription for self-care and health maintenance.

The OTC drugs and dietary supplement market consists of sales, by entities (organizations, sole traders and partnerships), of OTC drugs and dietary supplement. OTC drugs are used to treat various minor health issues, while dietary supplements provide nutritional support, such as vitamins, minerals, and other substances. These products are widely utilized by individuals seeking to manage minor ailments or boost their overall health without the need for medical consultation. They play a critical role in public health by offering accessible and often more affordable options for symptom relief and wellness.

The global OTC drug and dietary supplement market was valued at $223,312.9 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.

Rise In Pharma Research And Development (R&D) Expenditure

During the historic period, the rise in pharma research and development (R&D) expenditure drove the growth of the OTC drug and dietary supplement market. Increased investment in research and development (R&D) resulted in the creation of advanced OTC drugs and dietary supplements. These innovations encompassed superior formulations, enhanced delivery methods and improved safety standards, enhancing product appeal among consumers. For instance, according to a report published by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based pharmaceuticals-based trade association, in 2021 European health industries invested about 41.5 billion euros ($44.47 billion) for research and development (R&D) expenditure, an increase compared to 39.65 billion euros ($42.49 billion) in 2020. Therefore, a rise in pharma research and development (R&D) expenditure supported the growth of the OTC drug and dietary supplement market.

New Over-The-Counter Option For Opioid Overdose Reversal

Companies operating in the OTC drug and dietary supplement market are deploying new over-the-counter options for opioid overdose reversal. It facilitates access to a critical life-saving intervention, potentially lowering fatalities in emergency scenarios where immediate medical help may be limited or unavailable. For instance, in April 2024, Amneal Pharmaceuticals, Inc., a US-based generics and specialty pharmaceutical company, has announced the U.S. FDA approval and availability of its over-the-counter (OTC) Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg. This product is a generic equivalent to OTC NARCAN(R) HCI Nasal Spray and is intended for the emergency treatment of opioid overdoses, including those involving heroin, fentanyl and prescription opioids. Amneal's Naloxone HCI Nasal Spray is formulated to quickly reverse the life-threatening effects of an opioid overdose by binding to opioid receptors and restoring normal respiration within two to three minutes in individuals whose breathing has significantly slowed or stopped.

The global OTC drug and dietary supplement market is fragmented, with a few large number of players operating in the market. The top ten competitors in the market made up 21.5% of the total market in 2023.

OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global OTC drug and dietary supplement market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for OTC drug and dietary supplement? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The OTC drug and dietary supplement market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider OTC drug and dietary supplement market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by category, by dosage form and by distribution channel.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the OTC drug and dietary supplement market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by category, by dosage form and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for OTC drugs and dietary supplement providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Category: Vitamin And Dietary Supplements; Cough And Cold Dosage Forms; Analgesics; Gastrointestinal Dosage Forms; Skin; Other Categories
• 2) By Dosage Form: Tablets; Hard Capsules; Powders; Ointments; Soft Capsules; Liquids; Other Dosage Forms
• 3) By Distribution Channel: Pharmacies; Grocery Stores; Vitamin And Health Food Stores; Online Pharmacies
• Companies Mentioned: Nestle S.A.; Procter & Gamble Co.; Haleon plc; Abbott Laboratories; Sanofi S.A.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; OTC drug and dietary supplement indicators comparison.
• Data segmentations: Country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 OTC Drug And Dietary Supplement - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 OTC Drug And Dietary Supplement Market Definition And Segmentations
• 6.4 Market Segmentation By Category
  • 6.4.1 Vitamin And Dietary Supplements
  • 6.4.2 Cough And Cold Products
  • 6.4.3 Analgesics
  • 6.4.4 Gastrointestinal Products
  • 6.4.5 Skin
  • 6.4.6 Other Categories
• 6.5 Market Segmentation By Dosage Form
  • 6.5.1 Tablets
  • 6.5.2 Hard Capsules
  • 6.5.3 Powders
  • 6.5.4 Ointments
  • 6.5.5 Soft Capsules
  • 6.5.6 Liquids
  • 6.5.7 Other Dosage Forms
• 6.6 Market Segmentation By Distribution Channel
  • 6.6.1 Pharmacies
  • 6.6.2 Grocery Stores
  • 6.6.3 Vitamin And Health Food Stores
  • 6.6.4 Online Pharmacies

7 Major Market Trends

• 7.1 Expansion Of Production Capabilities In Dietary Supplements And OTC Drugs
• 7.2 New Over-The-Counter Option For Opioid Overdose Reversal
• 7.3 Launch Of Natural Herb-Based Supplement For Nursing Mothers
• 7.4 Introduction Of OTC Drug Line For Pain And Allergy Relief
• 7.5 Innovation In Women's Health Pharmaceuticals

8 OTC Drug And Dietary Supplement Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The OTC Drug And Dietary Supplement Market
• 8.2 Impact Of The War In Ukraine On The OTC Drug And Dietary Supplement Market
• 8.3 Impact Of High Inflation On The OTC Drug And Dietary Supplement Market

9 Global Market Size And Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global OTC Drug And Dietary Supplement Market Segmentation

• 10.1 Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 OTC Drug And Dietary Supplement Market, Regional and Country Analysis

• 11.1 Global OTC Drug And Dietary Supplement Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global OTC Drug And Dietary Supplement Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific OTC Drug And Dietary Supplement Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate tax structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe OTC Drug And Dietary Supplement Market: Country Analysis
• 13.6 UK Market
• 13.7 UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe OTC drug And Dietary Supplement Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America OTC Drug And Dietary Supplement Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America OTC Drug And Dietary Supplement Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Nestle S.A.
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 The Procter & Gamble Company
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Financial Overview
• 19.4 Haleon plc
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Abbott Laboratories
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Sanofi S.A
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

• 20.1 Reckitt Benckiser Group plc
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Bayer AG
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Church & Dwight Co. Inc
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Nature's Bounty Co
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Perrigo Company plc
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 GNC Holdings Inc.
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Sun Pharmaceutical Industries Ltd
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Novartis AG
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 Pfizer Inc
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Merck & Co. Inc
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 Pharmavite LLC
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Hain Celestial Group Inc
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 Blackmores Limited
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Cipla Inc
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Amway
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Dr. Reddy's Laboratories Acquired MenoLabs
• 23.2 Dexcel Pharma Acquired Teva Pharmaceutical Industries Ltd
• 23.3 Cipla Limited Acquired Actor Pharma
• 23.4 SGS S.A. Acquired Nutrasource Pharmaceutical and Nutraceutical Services Inc.
• 23.5 The Kirin Holdings Company Limited Acquired Blackmores Limited
• 23.6 Balchem Corporation Acquired Bergstrom Nutrition
• 23.7 Glenmark Pharmaceuticals Ltd Acquired Wockhardt Ltd
• 23.8 Acino Acquired Aspen Pharmacare Holdings Limited
• 23.9 Douglas Acquired Disapo
• 23.10 Merieux NutriSciences Acquired Dyad Labs
• 23.11 Laboratorios Rubio Acquired Fisiopharma S.r.l.
• 23.12 Fidia Farmaceutici Acquired Sanofi

24 Opportunities And Strategies

• 24.1 Global OTC Drug And Dietary Supplement Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global OTC Drug And Dietary Supplement Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global OTC Drug And Dietary Supplement Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 OTC Drug And Dietary Supplement Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer